TerrAscend (TSNDF) Cost of Revenue (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Cost of Revenue of $30.9 million for Q1 2026, up 4.44% year-over-year from $29.6 million in Q1 2025, and down 2.3% quarter-over-quarter from $31.7 million in Q4 2025.
TerrAscend (TSNDF) Cost of Revenue (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Cost of Revenue for 6 consecutive years, with $30.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue rose 4.44% year-over-year to $30.9 million; the TTM figure through Mar 2026 stood at $125.6 million (down 0.93% YoY), while the FY2025 annual figure was $124.2 million, down 6.03% from the prior year.
- Cost of Revenue eased to $30.9 million in Q1 2026 per TSNDF's latest filing, from $31.7 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $41.9 million in Q1 2024 and bottomed at -$339000.0 in Q4 2023.
- Historically, Cost of Revenue has averaged $32.5 million across 5 years, with a median of $33.0 million in 2022.
- Annual changes were most pronounced in 2023 — Cost of Revenue plunged 100.89% — and 2024, when it jumped 9338.64%.
- TerrAscend's Cost of Revenue stood at $38.2 million in 2022, then slumped by 100.89% to -$339000.0 in 2023, then surged by 9338.64% to $31.3 million in 2024, then grew by 1.11% to $31.7 million in 2025, then fell by 2.3% to $30.9 million in 2026.
- Business Quant data shows TSNDF's Cost of Revenue at $30.9 million in Q1 2026, $31.7 million in Q4 2025, and $31.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 30.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.87 Mn |
| Jun 30, 2026 | 30.87 Mn |
| Mar 31, 2026 | 30.94 Mn |
| Mar 31, 2026 | 30.94 Mn |
| Dec 31, 2025 | 31.67 Mn |
| Dec 31, 2025 | 31.67 Mn |
| Sep 30, 2025 | 31.18 Mn |
| Sep 30, 2025 | 31.18 Mn |
| Jun 30, 2025 | 31.77 Mn |
| Jun 30, 2025 | 31.77 Mn |
| Mar 31, 2025 | 29.62 Mn |
| Mar 31, 2025 | 29.62 Mn |
| Dec 31, 2024 | 31.32 Mn |
| Dec 31, 2024 | 31.32 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Jun 30, 2024 | 33.84 Mn |
| Jun 30, 2024 | 33.84 Mn |
| Mar 31, 2024 | 41.90 Mn |
| Mar 31, 2024 | 41.90 Mn |